A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...

Bishop Auckland, County Durham local Colette Cooper woke up one morning to notice that one of her breasts had grown overnight ...

AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...

A federal jury in Delaware found that Revance's rival product infringed patents for Allergan's market-leading neurotoxin ...

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in ...

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.

A MUM was terrified her boob job would kill her after it led to a rare disease. Colette Cooper went under the knife in 2014 ...

Pfizer and Allergan said the effective tax rate of the new company would be 17% to 18%, well below Pfizer’s effective tax rate last year of 25.5%.

U.S. pharmaceutical giant Pfizer (PFE) and Irish rival Allergan (AGN) Monday announced a record-breaking $160-billion merger, the largest in health-care industry history and the biggest yet ...

Actavis is nearing a deal to acquire Allergan in a tie-up that would likely be the year’s largest and could help shield the Botox maker from hostile suitor Valeant.

Valeant Pharmaceuticals raised its offer to buy Botox maker Allergan Inc., increasing the cash portion of its bid and lifting its overall value to more than $49 billion.